Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients

被引：0
|
作者：
Caraco, Y.
Giladi, N.
Oren, S.
LeWitt, P. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
349
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [31] Foslevodopa/foscarbidopa maintains stable levodopa and carbidopa exposure following subcutaneous infusion in Parkinson's disease patients
    Rosebraugh, M.
    Liu, W.
    Facheris, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 662 - 662
  • [32] DUODENAL CARBIDOPA/LEVODOPA: AN OPPORTUNITY FOR ADVANCED PARKINSON'S DISEASE PATIENTS
    Gayoso Rey, Monica
    Lopez Diaz, Luis Manuel
    ATENCION FARMACEUTICA, 2013, 15 (05): : 362 - 364
  • [33] The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease
    Cheron, Julian
    Deviere, Jacques
    Supiot, Frederic
    Ballarin, Asuncion
    Eisendrath, Pierre
    Toussaint, Emmanuel
    Huberty, Vincent
    Musala, Carmen
    Blero, Daniel
    Lemmers, Arnaud
    Van Gossum, Andre
    Arvanitakis, Marianna
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (01) : 60 - 68
  • [34] Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
    LeWitt, Peter
    Liang, Grace S.
    Olanow, C. Warren
    Kieburtz, Karl D.
    Jimenez, Roland
    Olson, Kurt
    Klepitskaya, Olga
    Loewen, Gordon
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (02) : 43 - 50
  • [35] Combined levodopa carbidopa with Entacapone improves the motor complications in advanced Parkinson's disease
    Ali, Md Ashraf
    MOVEMENT DISORDERS, 2016, 31 : S27 - S27
  • [36] Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
    Santos Garcia, Diego
    Martinez Castrillo, Juan Carlos
    Puente Periz, Vctor
    Seoane Urgorri, Agustin
    Fernandez Diez, Servando
    Benita Leon, Vicente
    Udaeta Baldivieso, Beatriz
    Campolongo Perillo, Antonia
    Mariscal Perez, Natividad
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (03) : 187 - 202
  • [37] Levodopa half-life with additional carbidopa in Parkinson's disease (PD) patients treated with carbidopa/levodopa and entacapone
    Parashos, SA
    Wielinski, CL
    Peterson, SM
    Brundage, RC
    MOVEMENT DISORDERS, 2005, 20 : S89 - S90
  • [38] POPULATION PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA FOLLOWING SUBCUTANEOUS INFUSION
    Birnberg, T.
    Adar, L.
    Smania, G.
    Bjornsson, M.
    Jonsson, N.
    Case, R.
    Karlsson, M. O.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 47 - 47
  • [39] Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study
    Olanow, C. Warren
    Espay, Alberto J.
    Stocchi, Fabrizio
    Ellenbogen, Aaron L.
    Leinonen, Mika
    Adar, Liat
    Case, Ryan J.
    Orenbach, Shir Fuchs
    Yardeni, Tami
    Oren, Sheila
    Poewe, Werner
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (01) : 177 - 186
  • [40] Levodopa/carbidopa/entacapone in early Parkinson's disease
    Reactions Weekly, 2020, 1798 (1) : 10 - 10
12345